Furthermore, the significant correlation between binding in FFPE samples of PSP patients and immunohistochemically assessed tau load supports the claim that the ARG signal is specific, but larger sample sizes are needed to confirm those assumptions. This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.